scholarly article | Q13442814 |
P2093 | author name string | C E Hart | |
F J Novembre | |||
H M McClure | |||
T R Gibson | |||
S P O'Neil | |||
J de Rosayro | |||
S Nidtha | |||
T Evans-Strickfaden | |||
P2860 | cites work | Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes | Q22251299 |
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection | Q29619099 | ||
Nonhuman primate models for AIDS. | Q30422377 | ||
Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis | Q33783919 | ||
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. | Q33783960 | ||
Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. | Q33927613 | ||
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys | Q34162184 | ||
Early appearance of antibodies to simian immunodeficiency virus in saliva and serum of infected macaques | Q35224769 | ||
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). | Q35617653 | ||
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. | Q35787838 | ||
Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo | Q35841911 | ||
Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques | Q35860556 | ||
A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. | Q35870467 | ||
Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1 | Q35884252 | ||
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome | Q36860939 | ||
The SCID-hu mouse: a small animal model for HIV infection and pathogenesis | Q37357883 | ||
The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations. | Q38474673 | ||
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. | Q39022595 | ||
Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections. | Q39582065 | ||
Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques. | Q39583105 | ||
Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees | Q40982879 | ||
A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge. | Q41059673 | ||
The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. | Q41178997 | ||
Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees. | Q41476865 | ||
Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants | Q43707249 | ||
The gastrointestinal tract and the pathogenesis of AIDS. | Q44163170 | ||
Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees | Q44246260 | ||
Persistent HIV-2 infection of rhesus macaque, baboon, and mangabeys | Q44503101 | ||
Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. | Q44992989 | ||
Different proliferative response of human and chimpanzee lymphocytes after contact with human immunodeficiency virus type 1 gp120. | Q45781425 | ||
Infection of chimpanzees with lymphadenopathy-associated virus | Q45806033 | ||
Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype | Q46812465 | ||
Progressive infection in a subset of HIV-1-positive chimpanzees. | Q52844171 | ||
Programmed cell death in AIDS-related HIV and SIV infections. | Q52847085 | ||
HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells. | Q52848179 | ||
Transmission of HTLV-III Infection from Human Plasma to Chimpanzees: An Animal Model for AIDS | Q52849903 | ||
Immunopathogenic mechanisms of HIV infection | Q71016167 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1533-1539 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzees | |
P478 | volume | 75 |
Q38659633 | AIDS in chimpanzees: the role of MHC genes |
Q36092834 | Apoptosis in SIV infection. |
Q37834099 | Coreceptor use in nonhuman primate models of HIV infection |
Q35745831 | DNA vaccines against human immunodeficiency virus type 1 in the past decade |
Q34357324 | Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees |
Q33442370 | Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee |
Q35108712 | Effects of MHC Class I on HIV/SIV Disease in Primates |
Q35149459 | Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii). |
Q31066870 | Going wild: lessons from naturally occurring T-lymphotropic lentiviruses |
Q21142612 | High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains |
Q38721695 | Limited MHC class I intron 2 repertoire variation in bonobos |
Q35120763 | Mitochondria in HIV-1-induced apoptosis. |
Q35049812 | Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials |
Q34436944 | Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors |
Q35677620 | Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas |
Q34715769 | Non-human primate models for AIDS vaccine research |
Q37110714 | Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate |
Q36758574 | Problems and emerging approaches in HIV/AIDS vaccine development |
Q30421288 | Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee host |
Q22065437 | Simian Immunodeficiency Virus Infection of Chimpanzees |
Q40191155 | Tackling HIV and AIDS: contributions by non-human primate models |
Q58395217 | The Evolution of Resistance to Simian Immunodeficiency Virus (SIV): A Review |
Q30431054 | The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future? |
Q89790289 | The HLA-A03 supertype and several Pan species' MHC-A allotypes share a preference for binding positively charged residues in the F pocket: implications for controlling retroviral infections |
Search more.